In this study, we hypothesized that FOXO4-DRI treatment could remove the senescent cells in the expanded chondrocytes, thus enhancing their potential in generating high-quality cartilage
FOXO4-DRI shows potential as a treatment targeting the senescence and apoptosis resistance, and holds promise as an approach to prevent the aggressiveness and relapse of keloids
12 Improved neuromuscular control through targeted training can enhance joint stability and reduce injury risks
It is important to remember that the majority of the current evidence is from animal studies or preliminary clinical trials and that to date, there is little information available on the side effects
The half-life of a drug is the time required for the serum concentration to be reduced by 50%
In summary, GHK-Cu acts as a molecular coordinator : stimulating collagen synthesis, recruiting cells to the wound site, forming new vessels, and neutralizing stress signals